{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Fountain Valley",
      "state": "CA",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "68170",
      "recalling_firm": "Bacai Inc. Dba Ky Duyen House",
      "address_1": "16165 Brookhurst St",
      "address_2": "N/A",
      "postal_code": "92708-1550",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Worldwide via internet sales",
      "recall_number": "D-1534-2014",
      "product_description": "Lite Fit USA, For Men & Women, Extreme Fat Burner, Suppresses Appetite, Boosts Metabolism, Limits Fat Absorption, Increases Energy, Prevents lipid formation by limiting fat absorption  30 pills /Bottle, Distributed by: Bacai, INC. www.litefitusa.com",
      "product_quantity": "14,040 softgel capsules",
      "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Bacai, Inc. DBA Ky Duyen House is voluntarily recalling Lite Fit USA, lot 13165, due to undeclared sibutramine, making it an unapproved new drug.",
      "recall_initiation_date": "20140430",
      "center_classification_date": "20140808",
      "termination_date": "20150210",
      "report_date": "20140820",
      "code_info": "Lot #13165; Exp. 05/17"
    }
  ]
}